Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dwyer

Showing results (231-240 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2014
Ferric citrate controls phosphorus and delivers iron in patients on dialysisJulia B Lewis, Mohammed Sika, Mark J Koury, et al.
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2016
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Kidney360|August 3, 2022
Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR StudyPaul E Drawz, Nayanjot Kaur Rai, Kristin Macfarlane Lenoir, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney DiseaseDeepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
Diabetes Care|July 8, 2021
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58Ofri Mosenzon, Stephen D Wiviott, Hiddo J L Heerspink, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Pageof 26

Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2014
Ferric citrate controls phosphorus and delivers iron in patients on dialysisJulia B Lewis, Mohammed Sika, Mark J Koury, et al.
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2016
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Kidney360|August 3, 2022
Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR StudyPaul E Drawz, Nayanjot Kaur Rai, Kristin Macfarlane Lenoir, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney DiseaseDeepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
Diabetes Care|July 8, 2021
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58Ofri Mosenzon, Stephen D Wiviott, Hiddo J L Heerspink, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Pageof 26